EdgarLookup

Outlook Therapeutics, Inc. — All Filings

777 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 25-NSE 3 3/A 4 4/A 424B3 424B4 424B5 8-A12B 8-A12B/A 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT FWP POS AM POS EX PRE 14A PRER14A S-1 S-1/A S-1MEF S-3 S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF ACTION UPLOAD
Form Description Accession Number Filed Period
POS AM POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-1 0001571049-18-000101 Feb 15, 2018
SC 13G/A SC 13G/A 0001144204-18-009078 Feb 15, 2018
8-K FORM 8-K 0001571049-18-000096 Feb 14, 2018 Feb 13, 2018
10-Q FORM 10-Q 0001571049-18-000094 Feb 14, 2018 Dec 31, 2017
SC 13G/A ONCOBIOLOGICS, INC. 0000902664-18-000892 Feb 12, 2018
8-K FORM 8-K 0001571049-18-000082 Feb 9, 2018
8-K FORM 8-K 0001144204-18-006335 Feb 7, 2018 Feb 1, 2018
10-K/A FORM 10-K/A 0001571049-18-000061 Jan 29, 2018 Sep 30, 2017
4 FORM 4 SUBMISSION 0001209191-18-002466 Jan 5, 2018 Jan 3, 2018
SC 13G/A SABBY 13G-A ONS 1.05.18 0001535610-18-000019 Jan 5, 2018
8-K FORM 8-K 0001144204-18-000830 Jan 4, 2018 Dec 28, 2017
S-3 FORM S-3 0001144204-18-000248 Jan 2, 2018
10-K FORM 10-K 0001571049-17-008779 Dec 29, 2017 Sep 30, 2017
4 FORM 4 SUBMISSION 0001209191-17-067235 Dec 26, 2017 Dec 22, 2017
4 FORM 4 SUBMISSION 0001209191-17-067233 Dec 26, 2017 Dec 22, 2017
4 FORM 4 SUBMISSION 0001209191-17-067232 Dec 26, 2017 Dec 22, 2017
4 FORM 4 SUBMISSION 0001209191-17-067229 Dec 26, 2017 Dec 22, 2017
4 FORM 4 SUBMISSION 0001209191-17-066693 Dec 20, 2017 Dec 18, 2017
4 FORM 4 SUBMISSION 0001209191-17-066692 Dec 20, 2017 Dec 18, 2017
4 FORM 4 SUBMISSION 0001209191-17-058967 Nov 2, 2017 Oct 31, 2017
4 FORM 4 SUBMISSION 0001209191-17-058966 Nov 2, 2017 Oct 31, 2017
4 FORM 4 SUBMISSION 0001209191-17-058965 Nov 2, 2017 Oct 31, 2017
4 FORM 4 SUBMISSION 0001209191-17-058963 Nov 2, 2017 Oct 31, 2017
3 OWNERSHIP DOCUMENT 0000947871-17-000867 Nov 1, 2017 Oct 31, 2017
3 OWNERSHIP DOCUMENT 0000947871-17-000866 Nov 1, 2017 Oct 31, 2017
4 OWNERSHIP DOCUMENT 0000947871-17-000865 Nov 1, 2017 Oct 31, 2017
SC 13D/A AMENDMENT NO. 1 0000947871-17-000864 Nov 1, 2017
8-K FORM 8-K 0001571049-17-008378 Oct 31, 2017 Oct 26, 2017
4 FORM 4 SUBMISSION 0001209191-17-058366 Oct 30, 2017 Oct 26, 2017
4 FORM 4 SUBMISSION 0001209191-17-058363 Oct 30, 2017 Oct 26, 2017
4 FORM 4 SUBMISSION 0001209191-17-058361 Oct 30, 2017 Oct 26, 2017
4 FORM 4 SUBMISSION 0001209191-17-058359 Oct 30, 2017 Oct 26, 2017
8-K FORM 8-K 0001571049-17-008115 Oct 6, 2017 Oct 2, 2017
CORRESP 0001571049-17-008073 Oct 3, 2017
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001571049-17-008054 Sep 29, 2017
DEF 14A DEFINITIVE PROXY STATEMENT 0001571049-17-008053 Sep 29, 2017 Oct 26, 2017
UPLOAD 0000000000-17-034588 Sep 28, 2017
PRER14A PRELIMINARY PROXY STATEMENT 0001571049-17-008023 Sep 27, 2017
UPLOAD 0000000000-17-034162 Sep 26, 2017
D 0001231919-17-000040 Sep 25, 2017
3/A OWNERSHIP DOCUMENT 0000947871-17-000753 Sep 25, 2017 Sep 7, 2017
3 OWNERSHIP DOCUMENT 0000947871-17-000742 Sep 18, 2017 Sep 11, 2017
3 OWNERSHIP DOCUMENT 0000947871-17-000741 Sep 18, 2017 Sep 11, 2017
3 OWNERSHIP DOCUMENT 0000947871-17-000740 Sep 18, 2017 Sep 7, 2017
SC 13D SCHEDULE 13D 0000947871-17-000736 Sep 18, 2017
PRE 14A PRELIMINARY PROXY STATEMENT 0001571049-17-007879 Sep 14, 2017
8-K FORM 8-K 0001144204-17-047463 Sep 11, 2017 Sep 7, 2017
424B3 PROSPECTUS SUPPLEMENT NO. 2 0001571049-17-007512 Aug 15, 2017
424B3 PROSPECTUS SUPPLEMENT NO. 2 0001571049-17-007511 Aug 15, 2017
424B3 PROSPECTUS SUPPLEMENT NO. 4 0001571049-17-007510 Aug 15, 2017